Anti-CD3 & BCMA Antibody (Teclistamab)
Catalog No.
F1390
Anti-CD3 & BCMA Antibody (Teclistamab)
Featured Products
Teclistamab is a humanized BCMA and CD3 bispecific antibody that can recognize BCMA on target cells and CD3 on T cells, induce T cell-mediated cytotoxicity, lead to T cell activation and subsequent target cell lysis. Teclistamab can be used for the study of multiple myeloma and other related diseases.
Quality Control & DataSheet
- View current batch:
-
Purity > 90% by SDS-PAGE and SEC-HPLC analyses.
- COA (Certificate Of Analysis)
- MSDS (Material Safety Data Sheet)
- Datasheet
187.86 kDa
Dry ice
2119595-80-9
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
NJ 7957, JNJ-64007959
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P07766 & Q02223
Human
Unconjugated
Monoclonal
Protein A
IgG4
ELISA, FACS, Kinetics, Functional assay, Animal Model
CD3 & BCMA
Please avoid freeze-thaw cycles.